Free CME's

Oncology Patient Navigator Training: the Fundamentals is organized by The George Washington University School of Medicine and Health Sciences. Expires: Dec 31, 2025 Accreditation: 12.00 Certified Health Education Specialist/Master Certified Health Education Specialist (CHES®/MCHES®) Description: Through a collaborative process, the GW Cancer Center developed the first-ever, national consensus-based competencies for oncology patient navigators without a clinical license. This comprehensive, competency-based training uses evidence-based information and case studies to prepare patient navigators to effectively address barriers to care for cancer patients and survivors. Additional details will be posted as soon as information is available...

Updates and Advances in Bone Marrow Failure Syndrome is organized by American Society of Pediatric Hematology/Oncology (ASPHO) and will be held on Feb 25, 2020. Additional details will be posted as soon as information is available.

3rd IBDH Annual Midwest Symposium is organized by IBDHorizons and will be held on Feb 29, 2020 at Hilton Columbus Downtown, Columbus, Ohio, United States of America. Target Audience: The target audience is comprised of healthcare providers caring for IBD patients: adult and pediatric gastroenterologists, advanced registered nurse practitioners and physician assistants, medical staff, dietician, surgeons, and pharmacists. Accreditation: The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. A maximum of 6.0 contact hours may be earned for successful completion of this activity. The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program # 0797-9999-20-002-L01-P. This program is designated for up to 6.0 contact hours (0.6 CEUs) of continuing pharmacy education credit. Activity Type: Knowledge. Statement of Need/Program Overview: This activity is provided by IBDHorizons. The management of IBD is highly dynamic with extensive, cutting-edge information deriving from a wealth of ongoing scientific, clinical, and therapeutic research programs. The mission of IBD Horizons® is to provide healthcare providers with the opportunity to enhance their clinical knowledge by providing the most up-to-date information regarding the management of IBD. Cutting edge topics delivered by respected educators/leaders in the IBD field, as well as opportunities for interaction between the presenters and participants, have been designed into the educational program. Learning Objectives: • Review the common extraintestinal manifestations in IBD apply practical approach to screen and intervene as needed • Appraise the currently available evidence of the effect of Cannabis and supplements in IBD  • Discuss the newly approved and soon to be approved biologic and non-biologic therapies for IBD, including the risks, efficacy and special considerations when utilizing these therapies • Describe and understand the comparative efficacy of the currently available therapies and the rationale for optimal positioning of these options in IBD today • Incorporate the concept of treat to target in IBD clinical practice and evaluate effectively how to incorporate into IBD management and goals of care • Examine the current management of fibrostenotic Crohn’s complications and apply best up-to-date medical and surgical treatment strategies • Apply up-to-date practice in managing dysplasia in IBD from detection to endoscopic and surgical intervention • Identify the most promising therapies including antibodies and small molecules in late-stage clinical development, with an emphasis on immunological targets and pharmacological properties  It is a gathering of the topmost renowned doctors in the field of IBD. It is an opportunity not to be missed to meet and discuss key topics with a highly select group of 150-200 colleagues. Topics and Speakers: • Approach to Managing Common IBD Extraintestinal Manifestations - Dr. Millie Long • Cannabis & Alternative Therapy in IBD: Good, Bad or ugly - Dr. Ghassan Wahbeh • The Evolving World of non-biologic therapies - Dr. Scott D. Lee • Comparative efficacy & positioning of IBD therapies today - Dr. Miguel Regueiro • Application of the Treat-To-Target Concept in Clinical Practice - Dr. Anita Afzali • Managing Fibrostenotic Crohn's Disease Complications - Dr. Christina Ha • Approach to managing Dysplasia in IBD - Dr. Feza Remzi • Promising Pathways and Upcoming Agents in IBD - Dr. Brian Feagan

IBD APP & Nurse Preceptorship Course is organized by Gastrointestinal Health Foundation (GiHF) and will be held on Feb 29, 2020 at Kimpton Hotel Eventi, New York City, New York, United States of America. Target Audience: This activity is designed for gastroenterology nurse practitioners, physician assistants and nurses from community-based practices. Accreditation: ANCC: A maximum of 18.25 contact hours may be earned for successful completion of this activity. AANP: This program is accredited for 18.25 contact hours. Program ID #5790. AAPA: This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 18.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Goal Statement: The primary goal of the educational activities proposed in this document is to encourage the application of the latest advances in evidence-based medicine to achieve improved outcomes for patients with IBD. Educational Objectives: Upon completion of this activity, participants should be able to: • Discuss the pathophysiology and current diagnostic strategies for IBD • Describe current management options for patients with IBD • Discuss the psychosocial impact of IBD and strategies for providing psychosocial support to patients and their families • Improve competence in caring for patients with IBD • Recognize barriers to optimal IBD treatment • Incorporate practical tools to manage access barriers and facilitate timely approval of therapies in IBD Additional details will be posted as soon as information is available.

Florida Blood Cancer Conference 2020 is organized by The Leukemia & Lymphoma Society (LLS) and will be held on Feb 29, 2020 at Fort Lauderdale Marriott Harbor Beach Resort & Spa, Fort Lauderdale, Florida, United States of America. The target audience for this medical event is for Patients, Survivors, Caregivers and Healthcare Professionals. Additional details will be posted as soon as the information is available.

26th edition of Medical Fair India, scheduled from 5 - 7 March 2020 at Bombay Convention and Exhibition Centre (BCEC), Goregoan, Mumbai. The show is being organized by Messe Dusseldorf India Pvt. Ltd., a 100% subsidiary of Messe Dusseldorf GmbH. Medical Fair India is India’s leading exhibition and conference for clinics, hospitals and health centers. The previous edition, MFI attracted over 580 exhibitors and more than 14,800 visitors in 2019 from diverse vertical of healthcare industry, both, domestic and international.  The following areas are covered by exhibitors: • Medical equipment & device • Medical technologies, heath care IT systems & solutions • Hospitals, health centres, clinics equipment and products • Laboratory and analytical equipment and products • Pharmacy and dispensary equipment and furniture • Rehabilitation, Orthopaedics & Physiotherapy • Measuring & testing equipment • Hospital & Healthcare infrastructure • Life sciences and Biotechnology Diagnostics • Analytical Equipment • Measuring and Testing • Components • Services Trade visitors: • Doctors, surgeons & practicing physician • Veterinarian • Dentists, Dental surgeons, Dental technicians • Physiotherapists, ergotherapists • Hospital directors & procurement managers • Biologists, microbiologists, bio-chemists • Medical laboratory, Pathologist • Manufacturer, Distributors & Traders • NGOs for rehabilitation aids • Government associations & International agencies Concurrent Conference along with the exhibition: • Clin Lab India Conference • Future for Hearth (FTRH4H) • Voice of Heath Care Conference (VOH) • Smart Hospitals - Conference Industry Awards: “MT India Health Care Awards” at Medical Fair India 2020

Transcatheter Mitral UK & Ireland is organized by Millbrook Medical Conferences Ltd and will be held on Mar 06, 2020 at The Principal York, York, England, United Kingdom. Description: This one-day conference will focus purely on Trans-catheter mitral intervention, including leaflet repair (Mitraclip and Pascal), TAVI-in-Mitral, and novel Transcatheter mitral repair and replacement techniques. Course Content: The course content will include focussed didactic presentations delivered by a faculty of UK, European, and North American experts, as well as live and recorded cases from UK centres. Who is this conference aimed at?: The conference is aimed at consultant interventional cardiologists, cardiac surgeons and imaging specialists in the UK & Ireland who are active in structural intervention, as well as Fellows specialising in structural work. This course is not suitable for AHPs or general PCI Interventional cardiologists.  Course Directors: Dan Blackman, David Hildick-Smith, Phil MacCarthy, Darren Mylotte, Dominik Schlosshan and Olaf Wendler We look forward to seeing you in March! Additional details will be posted as soon as information is available.

5th IBDH Annual Symposium - Seattle 2020 is organized by IBDHorizons and will be held on Mar 07, 2020 at Grand Hyatt Seattle, Seattle, Washington, United States of America.   The target audience is comprised of healthcare providers caring for IBD patients: adult and pediatric gastroenterologists, advanced registered nurse practitioners and physician assistants, medical staff, dietician, surgeons, and pharmacists.This CME Conference has been approved for a maximum of 6 AMA PRA Category 1 Credits™.   Description: 5th IBDH Annual Symposium - Seattle 2020. Meeting offers you: • Relevant and engaging presentations by renowned speakers • A forum to collaborate with others and ask questions and share your experiences • A place to reflect upon and refine your practices   Topics: Topics (Will be Updated) • Personalized Medicine: Individualizing treatment options for each patient with IBD • Medical and Surgical Management of Perianal Crohn’s Disease • Management of Severe Refractory Ulcerative Colitis • Surgical and Medical Management of the Failing Pouch • Management of Proctosigmoiditis failing Mesalamine • Management of Mild Crohn’s Ileitis • Treatment of the Pregnant IBD Patient with Active Disease • Choosing a Therapy from the Expanding Options   Statement of Need/Program Overview: • This activity is jointly provided by UI School of Medicine and IBD Horizons. • The management of IBD is highly dynamic with extensive, cutting-edge information deriving from a wealth of ongoing scientific, clinical, and therapeutic research programs. The mission of IBD Horizons® is to provide healthcare providers with the opportunity to enhance their clinical knowledge by providing the most up-to-date information regarding the management of IBD. Cutting edge topics delivered by respected educators/leaders in the IBD field, as well as opportunities for interaction between the presenters and participants, have been designed into the educational program.   Additional details will be posted as soon as they are available.

Diagnosing and Treating Irritable Bowel Syndrome (IBS-D) for Primary Care Clinicians is organized by University of Louisville (UL) School of Medicine and will be held on Mar 11, 2020 at Houston, Texas, United States of America. Target Audience: Internists, Family Physicians, Gastroenterologists, Physician Assistants, Nurse Practitioners and RN’s. Designation Statement: The University of Louisville School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses - This program has been approved by the Kentucky Board of Nursing for 1.2 continuing education credits through University of Louisville Hospital, provider number 4-0068-7-20-1125. Description: This activity will provide physicians and mid-level providers a good foundation of the symptoms, diagnostic approaches and treatment therapies for patients with irritable bowel syndrome with diarrhea (IBS-D) and IBS-C (constipation). Additional details will be posted as soon as they are available.

Laparoscopic Sacrocolpopexy: Tips & Tricks is organized by American Urogynecologic Society (AUGS) and will be held on Mar 11, 2020. Description: Minimally invasive sacrocolpopexy is becoming a more commonly performed procedure for both primary and recurrent pelvic organ prolapse. In this webinar, we will discuss pre-operative evaluation and planning for variations of sacrocolpopexy procedures, as well as techniques to improve the safety and efficacy of the procedure. Learning Objectives: • Discuss how preoperative evaluation of prolapse should influence the type of sacrocolpopexy performed. • Describe several techniques the surgeon can employ to improve exposure at the sacral promontory to allow safe dissection and suture placement. • Identify techniques to improve the efficiency and safety of suture placement and knot tying. • Describe different approaches to uterine preservation sacrohysteropexy. Additional details will be posted as soon as information is available.